Zimmer scores government contract

Zimmer Holdings has signed a deal with the Defense Department that could run through 2015.

The company will be awarded "a maximum $13,475,000 fixed-price with economic price adjustment, sole-source, indefinite-delivery/indefinite-quantity contract for orthopedic implantation products," according to a DoD statement on contracts. The services involved are the Army, Navy, Air Force and Marine Corps. The contract runs for one year with an option for four one-year options through March 31, 2015.

As Mass Device notes, this comes as a possible win for Zimmer, which saw its profits fall about 17 percent last year. The drop was largely due to a $204 million Q4 charge to its spinal unit's books.

Also, Zimmer CEO David Dvorak received total compensation of about $9.6 million last year, up from just over $7 million the year before, according to an SEC filing. His base salary was just over $833,000--up from $787,000 in 2009.

Zimmer shares declined 9.2 percent in 2010, according to Dow Jones. They have jumped up 12 percent this year so far.

- read the DoD news
- get more from Mass Device
- check out the Dow Jones report
- get the SEC filing

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.